Brief: Cstone Pharmaceuticals Got Investigational New Drug Approval By Nmpa For Cs2006/Nm21-1480
15/09/2021 01:12
CStone Pharmaceuticals 2616.HK :
* CSTONE PHARMACEUTICALS GOT INVESTIGATIONAL NEW DRUG
APPROVAL BY
NMPA FOR CS2006/NM21-1480
Source text for Eikon: ID:
Further company coverage: 2616.HK
Recent news on CStone Pharmaceuticals
See all newsBrief: CStone Pharmaceuticals Says CEO Purchases 496,000 Shares For Over HK$2.7 Million From Sept 17-22
Brief: CStone Pharmaceuticals Posts HY Loss Of Rmb252.3 Million
China's CStone Pharmaceuticals H1 revenue soars on drug sales
Brief: Cstone Pharmaceuticals Receives NMPA IND Approval For CS5007 In China
Brief: CStone Pharmaceuticals Says Directors And Senior Management Purchase 2.4 Million Shares In June 2026